Hennion & Walsh Asset Management, Inc. Zai Lab LTD Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.35 Billion
- Q2 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Zai Lab LTD stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 168,090 shares of ZLAB stock, worth $6.51 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
168,090
Previous 187,747
10.47%
Holding current value
$6.51 Million
Previous $7 Million
16.04%
% of portfolio
0.25%
Previous 0.33%
Shares
9 transactions
Others Institutions Holding ZLAB
# of Institutions
173Shares Held
48.9MCall Options Held
92.9KPut Options Held
318K-
Capital World Investors Los Angeles, CA6.01MShares$233 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X03.81MShares$148 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.65MShares$141 Million0.03% of portfolio
-
Clearbridge Investments, LLC New York, NY3.28MShares$127 Million0.11% of portfolio
-
Rtw Investments, LP New York, NY3.14MShares$121 Million1.86% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.79B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...